整体业绩显著改善，AD系列诊断产品有望迎来商业化
创新药周报：AD领域进展不断，关注抗体+小分子
Sri Lanka: Technical Assistance Report-Repeal of Simplified Value Added Tax and the Transition to Risk-Based Value Added Tax Refund Processing
–Game business weighed on revenue growth despite resilient ad and VAS business
维生素AD滴剂龙头，长期发展动力充足
汽车行业周报：零跑C16正式上市，阿维塔宣布首搭华为ADS 3.0
创新药周报：Lebrikizumab治疗度普利尤经治AD患者疗效与初治患者相近
Factoring in ads & games headwinds
阿尔茨海默病（AD）诊断与治疗带来医药领域新增长动力
Ad revenue growth recovery still takes time
公众号
小程序
社群